Beginning in 2005, the launch of next generation sequencing (NGS) technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests.
BCC Research provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status, and companies through its report, Next Generation Sequencing: Emerging Clinical Applications and Global Markets.
According to the report, the global next generation sequencing market was valued at nearly $510.7 million in 2013. The market should total nearly $7.6 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 71.6%.
Use this report to:
- Receive an in-depth analysis of the clinical next generation sequencing (NGS) industry.
- Learn about NGS technologies and its clinical applications.
- Examine information on industry structure and study the important clinical sequencing initiatives.
- Examine the sequencing industry structure for the key market segments, strategic alliances and acquisitions, and patents.
- Explore the ways in which next generation sequencing will be used in the diagnostic business during the next five years.
- Discuss the impact of new sequencing technologies on clinical diagnostics.
- Receive analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Receive detailed patent analysis and company profiles.
To order your copy of this report or its chapter(s) click here.
To download the complimentary Introduction of this report or to explore the detailed Table of Contents, click here.
Please email us at reports@bccresearch.org if you have any questions pertaining to this report.
Market Reports 